Westaim Net Common Equity Issued/Repurchased 2010-2024 | WEDXD
Westaim net common equity issued/repurchased from 2010 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
Westaim Annual Net Common Equity Issued/Repurchased
(Millions of US $) |
| 2023 |
$-26 |
| 2022 |
$-3 |
| 2021 |
$-1 |
| 2020 |
$ |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$172 |
| 2014 |
$132 |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
CHEM-SPECIALTY |
$0.461B |
$0.009B |
|
The Westaim Corporation is a technology accelerator that ensures its technology investments have the leadership, strategy, and capital to get into the marketplace as quickly as possible. Currently, Westaim has technology investments in three of the most important and fastest growing sectors of the economy: biomedical (Westaim Biomedical Corp.), semi-conductor/electronics (iFire Technology Inc.), and e-business software (Savvion).
|
